Geron Corporation

NASDAQ:GERN

Biotechnology

Healthcare
$0.91 +4.07%

+$0.05 today

Market cap
$588.19M
Beta
0.60
P/E (TTM)
-12.3
EPS (TTM)
-$0.10
52W Low $1.04High $2.01

Volume 19.64M

Average 16.28M

Income Statement

Follow revenue through to earnings.

Revenue

$183.88M

FY 2025 · Annual

+138.8% YoY

Operating Income

-$53.84M

FY 2025 · Annual

Net Income

-$85.78M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.39M596K237K76.99M183.88M
Cost of Revenue0001.26M4.75M
Gross Profit1.39M596K237K75.74M179.14M
Gross Margin100.0%100.0%100.0%98.4%97.4%
Research & Development85.73M95.52M125.05M103.74M73.72M
Selling, General & Admin29.67M43.63M69.14M145.73M159.26M
Operating Expenses115.39M139.15M194.18M249.47M232.97M
Depreciation & Amortization783K868K1.03M1.22M1.2M
EBITDA(111.59M)(134.15M)(174.78M)(154.85M)(51.92M)
EBITDA Margin-8010.7%-22508.6%-73747.7%-201.1%-28.2%
Operating Income(114M)(138.55M)(193.94M)(173.73M)(53.84M)
Operating Margin-8183.7%-23246.6%-81832.9%-225.6%-29.3%
Interest Income527K2.53M18.15M19.61M18.12M
Interest Expense3.74M6.88M8.31M18.5M32.66M
Other Income / Expenses(2.11M)(3.35M)9.82M(840K)(31.95M)
Income Before Tax(116.11M)(141.9M)(184.13M)(174.57M)(85.78M)
Pre-Tax Margin-8335.4%-23808.9%-77690.7%-226.7%-46.7%
Income Tax Expense00000
Net Income(116.11M)(141.9M)(184.13M)(174.57M)(85.78M)
Net Margin-8335.4%-23808.9%-77690.7%-226.7%-46.7%
EPS (Basic)(0.37)(0.37)(0.32)(0.27)(0.13)
EPS (Diluted)(0.37)(0.37)(0.32)(0.27)(0.13)
Weighted Avg Shares327.63M380.78M570.65M646.03M666.66M
Weighted Avg Shares (Diluted)327.63M380.78M570.65M646.03M666.66M

GERN Earnings Waterfall · TTM

NASDAQ:GERN · Revenue to Net Income

Key Ratios

EPS$-0.10
Gross Margin86.2%
Net Margin-36.1%
P/E Ratio-25.6
P/S Ratio19.0

Analysis

$196.1M of revenue converted into -$69.6M of net income for the selected period. Gross margin is 86.2% and net margin is -36.1%, showing how much revenue survives after costs and taxes. EPS is $-0.10, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportOct 28, 2026
4Statement of changes in beneficial ownershipOct 1, 2026

How much revenue does GERN generate?

Geron Corporation (GERN) reported $183.88M of revenue in fiscal 2025.

Is GERN profitable?

Geron Corporation (GERN) reported -$85.78M of net income, with a net margin of -46.7%.